The Magazine for Sleep Professionals
Saturday, March 21, 2026
International Biophysics Corporation, manufacturer of the AffloVest is committed to raising awareness of Cystic Fibrosis and the importance of airway clearance therapy in the management of the disease. Over 30,000 people in the U.S. and 70,000 worldwide struggle with the effects of cystic fibrosis every day. There is no cure […]
Electromed, Inc. announced the results of an independent, outcome-based clinical study presented during the third annual World Bronchiectasis Conference in Washington D.C. The study’s findings reveal that early use of high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduced severe exacerbations and hospitalizations among non-cystic […]
Electromed, Inc. maker of airway clearance technologies, announced that the Internal Revenue Service has agreed to refund the company approximately $406,000 related to federal medical device excise taxes paid on revenue associated with the sales of its SmartVest® Airway Clearance System during the company’s tax periods ended June 30, 2014 […]
Synspira, a privately held company developing a new class of inhaled glycopolymer-based therapeutics for the treatment of pulmonary disease, announced that it has received up to a $3 million award from the Cystic Fibrosis (CF) Foundation to advance clinical development of its lead candidate, SNSP113, for use in pulmonary complications […]
